The trading price of Heron Therapeutics Inc (NASDAQ:HRTX) closed lower on Friday, April 19, closing at $2.64, -2.58% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $3.22 and a 52-week low of $0.50. Over the past month, the stock has lost -13.44% in value.
Heron Therapeutics Inc, whose market valuation is $396.87 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Heron Therapeutics Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest HRTX has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that HRTX’s price is currently -5.48% off the SMA20 and -3.15% off the SMA50. The RSI metric on the 14-day chart is currently showing 44.00, and weekly volatility stands at 7.95%. When measured over the past 30 days, the indicator reaches 6.87%. Heron Therapeutics Inc (NASDAQ:HRTX)’s beta value is currently sitting at 1.68, while the Average True Range indicator is currently displaying 0.20.
To see how Heron Therapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: HRTX stock’s performance was -2.58% in the latest trading, and -2.22% in the past year.
An evaluation of the daily trading volume of Heron Therapeutics Inc (NASDAQ:HRTX) indicates that the 3-month average is 2.61 million.
Currently, records show that 150.29 million of the company’s shares remain outstanding. The insiders hold 5.08% of outstanding shares, whereas institutions hold 71.10%. However, since the stock’s price has seen 55.29% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
